TLR-Mediated Signal Transduction and Neurodegenerative Disorders
Open accessThe DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
A special class of proteins called Toll-like receptors (TLRs) are an essential part of the innate immune system, connecting it to the adaptive immune system. There are 10 different Toll-Like Receptors that have been identified in human beings. TLRs are part of the central nervous system (CNS), showing that the CNS is capable of the immune response, breaking the long-held belief of the brain’s “immune privilege” owing to the blood–brain barrier (BBB). These Toll-Like Receptors are present not just on the resident macrophages of the central nervous system but are also expressed by the neurons to allow them for the production of proinflammatory agents such as interferons, cytokines, and chemokines; the activation and recruitment of glial cells; and their participation in neuronal cell death by apoptosis. This study is focused on the potential roles of various TLRs in various neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD), namely TLR2, TLR3, TLR4, TLR7, and TLR9 in AD and PD in human beings and a mouse model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TLRs are widely expressed in neural cells, including microglia, astrocytes, oligodendrocytes, neurons and so on.281”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [281]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: miR-599 inhibits proliferation and invasion of glioma by targeting periostin
Zhang, T., Ma, G., Zhang, Y., Huo, H., & Zhao, Y. (2017) · Biotechnology Letters · doi:10.1007/s10529-017-2365-7 · Cited by 25
RetractedDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,235
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Structure of an IκBα/NF-κB Complex
Jacobs, M. D., & Harrison, S. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81698-0 · Cited by 821
An unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration
Lehmann, S. M., Krüger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3113 · Cited by 786
What is immune privilege (not)?
Galea, I., Bechmann, I., & Perry, V. H. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.004 · Cited by 768 · cited 1×
“This regulation process is indispensable for damage limitation and mitigation in this sensitive organ [20].”
BackgroundToll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
MyD88: a central player in innate immune signaling
Deguine, J., & Barton, G. M. (2014) · F1000Prime Reports · doi:10.12703/p6-97 · Cited by 692 · cited 1×
“MyD88 is a pivotal molecule in the modulation of the innate immune response because it is the adaptor known to transduce the signal from TLRs by activation of IL-1 receptor associated kinases (IRAKs) via homotypic protein–protein interaction, which eventually leads to the activation of nuclear factor-kappa B (NFκB), m…”
BackgroundHerpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis
Kurt-Jones, E. A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., Arnold, M. M., Knipe, D. M., & Finberg, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308057100 · Cited by 611
Toll-like receptors activation, signaling, and targeting: an overview
El-Zayat, S. R., Sibaii, H., & Mannaa, F. A. (2019) · Bulletin of the National Research Centre · doi:10.1186/s42269-019-0227-2 · Cited by 556
Role of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease
Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schüffer, W., et al. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110455 · Cited by 543
Triantafilou, M., Gamper, F. G. J., Haston, R. M., Mouratis, M. A., Morath, S., Hartung, T., & Triantafilou, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602794200 · Cited by 460
Jang, H., Boltz, D., Sturm-Ramirez, K., Shepherd, K. R., Jiao, Y., Webster, R., & Smeyne, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900096106 · Cited by 459
Virus Infection Switches TLR-3-Positive Human Neurons To Become Strong Producers of Beta Interferon
Préhaud, C., Mégret, F., Lafage, M., & Lafon, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12893-12904.2005 · Cited by 361
Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3
Sasai, M., Linehan, M. M., & Iwasaki, A. (2010) · Science · doi:10.1126/science.1187029 · Cited by 357
Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer’s Disease
Jana, M., Palencia, C. A., & Pahan, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7254 · Cited by 330
Toll-Like Receptors, Associated Biological Roles, and Signaling Networks in Non-Mammals
Nie, L., Cai, S.-Y., Shao, J.-Z., & Chen, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01523 · Cited by 329
Richard, K. L., Filali, M., Préfontaine, P., & Rivest, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1146-08.2008 · Cited by 298
Toll-like Receptors 3, 4, and 7 Are Expressed in the Enteric Nervous System and Dorsal Root Ganglia
Barajon, I., Serrao, G., Arnaboldi, F., Opizzi, E., Ripamonti, G., Balsari, A., & Rumio, C. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953539 · Cited by 287 · cited 2×
“While the Schwann cells in mice are known to express TLRs 1 to 9, only TLR2 has been very well studied and characterized in human Schwann cells [21,29,30].”
BackgroundJin, J.-J., Kim, H.-D., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-23 · Cited by 275
Lien, E., & Ingalls, R. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201001-00001 · Cited by 273
Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons
Stefanova, N., Fellner, L., Reindl, M., Masliah, E., Poewe, W., & Wenning, G. K. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.013 · Cited by 272
Differential expression of Toll-like receptor 2 in human cells
Flo, T. H., Halaas, Ø., Torp, S., Ryan, L., Lien, E., Dybdahl, B., Sundan, A., & Espevik, T. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.3.474 · Cited by 255
Modulation of adaptive immunity with Toll-like receptors
Manicassamy, S., & Pulendran, B. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.005 · Cited by 255
Doorn, K. J., Moors, T., Drukarch, B., van de Berg, W. D., Lucassen, P. J., & van Dam, A.-M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0090-1 · Cited by 254
Trigeminal Nociceptors Express TLR-4 and CD14: a Mechanism for Pain due to Infection
Wadachi, R., & Hargreaves, K. M. (2006) · Journal of Dental Research · doi:10.1177/154405910608500108 · Cited by 240
Sweeten PAMPs: Role of sugar complexed PAMPs in innate immunity and vaccine biology
Mahla, R. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00248 · Cited by 239 · cited 1×
“To date, 19 TLRs have been observed and reported in humans, though many different TLRs are also present in other mammals in different combinations with different functions [4].”
BackgroundToll-Like Receptor 3 Is a Potent Negative Regulator of Axonal Growth in Mammals
Cameron, J. S., Alexopoulou, L., Sloane, J. A., DiBernardo, A. B., Ma, Y., Kosaras, B., Flavell, R., Strittmatter, S. M., Volpe, J., Sidman, R., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4290-06.2007 · Cited by 233
Tang, S.-C., Lathia, J. D., Selvaraj, P. K., Jo, D.-G., Mughal, M. R., Cheng, A., Siler, D. A., Markesbery, W. R., Arumugam, T. V., & Mattson, M. P. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.014 · Cited by 232 · cited 2×
“Much like the case of TLR2, neurons respond to Aβ and AD-related metabolites through TLR4, leading to their apoptosis [36].”
BackgroundRos-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017820108 · Cited by 231 · cited 1×
“TLR9 has been observed to be overexpressed in human brain regions such as the substantia nigra and putamen in PD patients and in the brain stem in PD mouse models [58].”
BackgroundToll-Like Receptor 3 Is a Negative Regulator of Embryonic Neural Progenitor Cell Proliferation
Lathia, J. D., Okun, E., Tang, S.-C., Griffioen, K., Cheng, A., Mughal, M. R., Laryea, G., Selvaraj, P. K., ffrench-Constant, C., Magnus, T., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2140-08.2008 · Cited by 206
Fang, W., Bi, D., Zheng, R., Cai, N., Xu, H., Zhou, R., Lu, J., Wan, M., & Xu, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-01868-0 · Cited by 203
α-Synuclein Alters Toll-Like Receptor Expression
Béraud, D., Twomey, M., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., Chasovskikh, S., Mhyre, T. R., & Maguire-Zeiss, K. A. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00080 · Cited by 198
Innate Cellular Response to Virus Particle Entry Requires IRF3 but Not Virus Replication
Collins, S. E., Noyce, R. S., & Mossman, K. L. (2004) · Journal of Virology · doi:10.1128/jvi.78.4.1706-1717.2004 · Cited by 198
Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9)
Iliev, A. I., Stringaris, A. K., Nau, R., & Neumann, H. (2004) · The FASEB Journal · doi:10.1096/fj.03-0670fje · Cited by 192 · cited 1×
“In a co-culture containing microglia and neurons, the activation of microglia cells by CpG-DNA via TLR9 induced neuronal toxicity, mediated partly through TNF-α [60].”
BackgroundThe Innate Immune Facet of Brain: Human Neurons Express TLR-3 and Sense Viral dsRNA
Lafon, M., Megret, F., Lafage, M., & Prehaud, C. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:29:3:185 · Cited by 181
Minoretti, P., Gazzaruso, C., Vito, C. D., Emanuele, E., Bianchi, M., Coen, E., Reino, M., & Geroldi, D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.047 · Cited by 164
How Location Governs Toll‐Like Receptor Signaling
Chaturvedi, A., & Pierce, S. K. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00899.x · Cited by 164
Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
Noelker, C., Morel, L., Lescot, T., Osterloh, A., Alvarez-Fischer, D., Breloer, M., Henze, C., Depboylu, C., Skrzydelski, D., Michel, P. P., et al. (2013) · Scientific Reports · doi:10.1038/srep01393 · Cited by 164 · cited 2×
“These observations suggest that TLR4 might be neuroprotective in the context of PD, as TLR4 could help in the clearance of toxic aggregates but could cause neurodegeneration in the context of toxin-induced PD, for example in patients who are in contact with agents such as MPTP or rotenone.”
BackgroundImmunostimulatory CpG-DNA Activates Murine Microglia
Dalpke, A. H., Schäfer, M. K.-H., Frey, M., Zimmermann, S., Tebbe, J., Weihe, E., & Heeg, K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4854 · Cited by 163
Toll‐like receptor expression in the peripheral nerve
Goethals, S., Ydens, E., Timmerman, V., & Janssens, S. (2010) · Glia · doi:10.1002/glia.21041 · Cited by 158
Role of Toll Like Receptor 4 in Alzheimer’s Disease
Calvo-Rodriguez, M., García-Rodríguez, C., Villalobos, C., & Núñez, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01588 · Cited by 136 · cited 1×
“Knocking out TLR4 in AD mouse models showed reduced expression of TNFα and the chemokine macrophage inflammatory protein 1β in the cortex [40], though knocking TLR4 out of AD mice led to an increase in the activated microglia, astrocytes, and Aβ protein in the brain [41].”
BackgroundToll-Like Receptors in Alzheimer’s Disease: A Therapeutic Perspective
Gambuzza, M., Sofo, V., Salmeri, F., Soraci, L., Marino, S., & Bramanti, P. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140806124850 · Cited by 131
McKimmie, C. S., & Fazakerley, J. K. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.006 · Cited by 126
Toll-Like Receptors in Atherosclerosis
Falck-Hansen, M., Kassiteridi, C., & Monaco, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714008 · Cited by 126
WDFY1 mediates TLR3/4 signaling by recruiting TRIF
Hu, Y., Zhang, Y., Jiang, L., Wang, S., Lei, C., Sun, M., Shu, H., & Liu, Y. (2015) · EMBO Reports · doi:10.15252/embr.201439637 · Cited by 109
Jackson, A. C., Rossiter, J. P., & Lafon, M. (2006) · Journal of NeuroVirology · doi:10.1080/13550280600848399 · Cited by 108
Lotz, M., Ebert, S., Esselmann, H., Iliev, A. I., Prinz, M., Wiazewicz, N., Wiltfang, J., Gerber, J., & Nau, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03188.x · Cited by 104
Toll-like receptor modulators: a patent review (2006 – 2010)
Basith, S., Manavalan, B., Lee, G., Kim, S. G., & Choi, S. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.569494 · Cited by 103
Hepatitis C virus infection: a risk factor for Parkinson's disease
Wu, W. Y. ‐., Kang, K. ‐., Chen, S. L. ‐., Chiu, S. Y. ‐., Yen, A. M. ‐., Fann, J. C. ‐., Su, C. ‐., Liu, H. ‐., Lee, C. ‐., Fu, W. ‐., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12392 · Cited by 88
Rosenberger, K., Derkow, K., Dembny, P., Krüger, C., Schott, E., & Lehnardt, S. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0166-7 · Cited by 84
Hypothesis: A role for EBV-induced molecular mimicry in Parkinson's disease
Woulfe, J., Gray, M. T., Gray, D. A., Muñoz, D. G., & Middeldorp, J. M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.031 · Cited by 71
Extracellularly Delivered Single-Stranded Viral RNA Causes Neurodegeneration Dependent on TLR7
Lehmann, S. M., Rosenberger, K., Krüger, C., Habbel, P., Derkow, K., Kaul, D., Rybak, A., Brandt, C., Schott, E., Wulczyn, F. G., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201078 · Cited by 64
Rietdijk, C. D., Van Wezel, R. J. A., Garssen, J., & Kraneveld, A. D. (2016) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2015.28 · Cited by 59
Zhou, C., Sun, X., Hu, Y., Song, J., Dong, S., Kong, D., Wang, Y., Hua, X., Han, J., Zhou, Y., et al. (2019) · Aging · doi:10.18632/aging.102260 · Cited by 50 · cited 2×
“Clinical studies have shown that TLR2 is overexpressed in the microglia of patients with Parkinson’s disease (PD), especially in the substantia nigra and the hippocampus region of the brain in the early stages of the disease [33].”
BackgroundTauber, S. C., Ebert, S., Weishaupt, J. H., Reich, A., Nau, R., & Gerber, J. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b7fde5 · Cited by 39
Host species adaptation of TLR5 signalling and flagellin recognition
Tahoun, A. A. E., Jensen, K., Corripio‐Miyar, Y., McAteer, S. P., Smith, D. G., McNeilly, T. N., Gally, D. L., & Glass, E. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-17935-5 · Cited by 37
Schütze, S., Loleit, T., Zeretzke, M., Bunkowski, S., Brück, W., Ribes, S., & Nau, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120856 · Cited by 27
Kalinderi, K., Bostantjopoulou, S., Katsarou, Z., & Fidani, L. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1106-x · Cited by 22
Does HIV Infection Alter Parkinson Disease?
Moulignier, A., Guéguen, A., Lescure, F.-X., Ziegler, M., Girard, P., Cardon, B., Pialoux, G., Molina, J., Brandel, J., & Lamirel, C. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000677 · Cited by 22
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“TLRs are widely expressed in neural cells, including microglia, astrocytes, oligodendrocytes, neurons and so on.(281) It has been reported that TLRs are upregulated in the brains of patients with neurodegenerative diseases.”
BackgroundAllicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment
Nadeem, M. S., Kazmi, I. A., Ullah, I., Muhammad, K., & Anwar, F. (2021) · Antioxidants · doi:10.3390/antiox11010087 · Cited by 153
“The toll like receptors (TLRs) are important components of immune system that recognize foreign ligands and induce inflammation by the activation of corresponding signaling molecules [112,113].”
BackgroundToll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions
Squillace, S., & Salvemini, D. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.05.004 · Cited by 117
Saber, M. M., Monir, N., Awad, A. S., Elsherbiny, M. E., & Zaki, H. F. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120874 · Cited by 64
Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Galizzi, G., & Carlo, M. D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110540 · Cited by 44
“The activation of the TLR9/NF-κ B pathway promotes inflammation by inducing the expression of TNF-α [140,141], IFN-I, and pro-inflammatory cytokines [142,143] (Figure 2).”
Background
Metadata
- Authors
- Adhikarla, S. V., Jha, N. K., Goswami, V. K., Sharma, A., Bhardwaj, A., Dey, A., Villa, C., Kumar, Y., & Jha, S. K.
- Affiliations
- University of Delhi (IN)
- Sharda University (IN)
- Delhi Technological University (IN)
- Presidency University (IN)
- University of Milano-Bicocca (IT)
- Corresponding author
- Kumar, Yatender
- Jha, Saurabh Kumar
- ORCID
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2021-10-20
- Volume
- 11
- Issue
- 11
- Pages
- 1373
- ISSN
- 2076-3425 (ISSN-L)
- PMC
- PMC8615980
- OpenAlex
- W3205342976
- Cited by
- 50
- References
- 63
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 16 · 2023: 8 · 2022: 7 · 2021: 1
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Toll-like receptors, neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, innate immunity, blood-brain barrier, neuroinflammation, TLR2, TLR3, TLR4, TLR7, TLR9, glial activation, apoptosis, central nervous system
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

